Wenwei Liao

Papers

Total Citations

H-Index

About

Dr. Wenwei Liao is a leading figure in minimally invasive pancreatic surgery, with a focused expertise in comparing robotic and laparoscopic approaches for pancreatic ductal adenocarcinoma (PDAC). His seminal 2021 systematic review and meta-analysis, which has garnered 18 citations, directly addressed the contentious debate surrounding robotic distal pancreatectomy (RDP) versus laparoscopic distal pancreatectomy (LDP) for PDAC. By rigorously synthesizing available evidence, Dr. Liao provided critical insights into the safety, oncologic efficacy, and perioperative outcomes of these two techniques, helping to clarify their respective roles in treating pancreatic body and tail tumors. This work has become a foundational reference for surgeons and researchers navigating the evolving landscape of minimally invasive pancreatic surgery. Beyond this key contribution, Dr. Liao’s research portfolio consistently explores surgical innovation and evidence-based practice, aiming to improve patient outcomes through comparative effectiveness studies. His meta-analysis not only highlights his methodological rigor but also underscores his commitment to advancing surgical decision-making, making him a respected voice in the field of hepatopancreatobiliary surgery.